Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01186042 · ClinicalTrials.gov registry record
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 21
- Enrollment target
NCT01186042: Completed study, sponsored by University of Nebraska.
NCT01186042 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01186042 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to find the best tests to use to investigate the differences between older and younger people with HIV disease. Test to be included will measures of memory, learning, activity levels, sleep patterns, emotional well-being and sexual health.
Primary Outcome
Evaluate the feasibility of enrolling older HIV-infected patients and youger controls into a prospective, observational study.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-08-01 |
| Est. Completion | 2014-12-17 |
What the finished NCT01186042 record still lists
NCT01186042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT01186042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01186042 about?
NCT01186042 is a clinical study titled "Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)". The purpose of this study is to find the best tests to use to investigate the differences between older and younger people with HIV disease. Test to be included will measures of memory, learning, activity levels, sleep patterns, emotional well-being and sexual health.
What is the current status of trial NCT01186042?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2010-08-01. Estimated completion is 2014-12-17.
What interventions are being tested in trial NCT01186042?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT01186042?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI